Blood Advances
Publisher: Elsevier · ISSN 2473-9529 · 89 articles
- Treatment journey and outcomes of patients with RRMM after quadruple-class exposure: a critical unmet need
- Assessing Differences in Timeliness of Emergency Department Pain Treatment for Adult Sickle Cell Pain and Renal Colic.
- Iron Deficiency in Children Across Ferritin Methods
- Combined inhibition of BCL2 activity and CD28 signaling to prevent graft-versus-host disease
- Targeting smoldering myeloma and monoclonal gammopathy of undetermined significance using multi-antigen specific T cells
- Hematologic care for transgender and gender-diverse people
- Affordable cure within reach for thalassemia
- Duffy-null screening in children: testing for all?
- The diagnosis of iron deficiency: progress toward consensus
- NLRC4 inflammasome: a key driver in TET2-deficient MDS
- Heterogeneity and GRADE in recurrent VTE prognosis
- Looking beyond the perfect (mis)match
- Risk factors for CRS and ICANS with bispecific antibodies for aggressive lymphomas
- Evaluation of modern hematology-oncology home call: optimizing patient care, physician well-being, and trainee education
- Unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation
- Early response and genetics define relapse risk after frontline blinatumomab in childhood B-ALL: a cohort study
- A hemoglobin >120 g/L trends toward improved survival without increasing vascular events in patients with MDS treated with ESAs
- Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant
- A curative-intent treatment program in older AML: mature posttransplant results from the VEN-DEC GITMO study
- The hematology workforce in the United States: past, present, and strategies for the future
- Sustaining cell therapy quality through shared responsibility: a call for equitable FACT inspectorate participation
- American Society of Hematology 2026 guidelines for diagnosis of iron deficiency
- The complexity of provoked venous thromboembolism: one treatment plan does not fit all
- Reframing hematologic and thrombovascular care for transgender and gender-diverse individuals: a scoping review
- Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200
- Central nervous system involvement in children with hemophagocytic lymphohistiocytosis: an HLH-2004 study report
- Life-years saved by advances in blood cancer therapy: a retrospective analysis
- Duffy testing to benefit children’s population health: a cost-effectiveness analysis
- Chemotherapy-related anemia is regulated through caspase-1–mediated ROCK1 activation
- Molecular profiling and disease tracking of posttransplant lymphoproliferative disorders using cell-free DNA